InvestLog
Back to Market返回行情

128940.KS Hanmi Pharm. Co., Ltd.

KSCHealthcare
₩392,500+0.38%LatestMarket Cap: ₩5.03T

As of 2026-08-09 03:18

Why 128940.KS matters now

Hanmi Pharm. Co., Ltd. (128940.KS) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩392,500.00 with +0.38% on the session and ₩5.03T in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 21.27, gross margin 41.3%, and operating margin 17.3%.

Valuation

P/E (TTM)

21.27

PEG

—

P/B

3.90

P/S

3.01

EV/EBITDA

14.50

DCF Value

—

FCF Yield

2.9%

Div Yield

0.5%

Margins & Returns

Gross Margin

41.3%

Operating Margin

17.3%

Net Margin

13.2%

ROE

17.9%

ROA

9.8%

ROIC

12.3%

Listing Info

Market

Korea

Exchange

KSC

Currency

KRW

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

KR

A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.